The presence of the NIS on the basal membrane of certain tumor cells, such as those in DTC, cholangiocarcinoma and hepatocellular carcinoma, facilitates iodine uptake and forms the basis for radioiodine therapy (35). This evidence concerns the gene SLC5A5 and neoplasm.